Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-120.62	-200.4	-177.12	-101.94	-87.76	-58.57
Depreciation & Amortization	0.6	0.53	0.55	0.43	0.29	2.93
Stock-Based Compensation	10.58	13.5	14.34	11.52	10.58	13.27
Other Adjustments	-5.88	-6.65	-2.33	0.74	0.1	-130.68
Change in Receivables	0.44	-2.46	-0.98	-0.01	0.38	53.23
Changes in Inventories	0.42	0.15	-0.38	-	-	0.35
Changes in Accounts Payable	7.43	14.8	6.45	0.08	-14.16	-20.97
Changes in Other Operating Activities	5.14	1.75	-2.43	0.34	3.55	-1.52
Operating Cash Flow	-101.9	-178.78	-161.9	-88.85	-87.02	-142.97
Capital Expenditures	-	-1.03	-0.47	-1.33	-1.22	-0.09
Sale of Property, Plant & Equipment	-	-	-	-	-	11.01
Purchases of Investments	-159.39	-328.75	-223.34	-133.95	-34.26	-58.56
Proceeds from Sale of Investments	323.41	314.4	173.87	64.2	37.59	268
Proceeds from Business Divestments	-	-	-	-	-	160.39
Investing Cash Flow	163.23	-15.38	-49.94	-71.08	2.11	380.76
Long-Term Debt Issued	-	-	49.96	48.87	-11.7	-216.58
Net Long-Term Debt Issued (Repaid)	-	-	49.96	48.87	-11.7	-216.58
Issuance of Common Stock	-	0.06	138.82	94.21	37.08	69.97
Repurchase of Common Stock	-	-1.73	-0.82	-0.86	-2.68	-1.03
Net Common Stock Issued (Repurchased)	-	-1.67	138	93.34	34.41	68.94
Issuance of Preferred Stock	-	241.32	-	-	-	-
Net Preferred Stock Issued (Repurchased)	-	241.32	-	-	-	-
Other Financing Activities	-	-1.31	-	-	-	-
Financing Cash Flow	-46.59	238.35	187.96	142.21	22.71	-147.64
Net Cash Flow	14.75	44.19	-23.88	-17.72	-62.2	90.15
Beginning Cash & Cash Equivalents	35.62	22.47	46.35	64.07	126.26	36.11
Ending Cash & Cash Equivalents	50.36	66.66	22.47	46.35	64.07	126.26
Free Cash Flow	-101.9	-179.81	-162.37	-90.18	-88.24	-143.06
FCF Margin	-1730.55%	-578.52%	-13485.63%	-64875.54%	-29610.07%	-596.19%
Free Cash Flow Per Share	-0.28	-0.56	-0.73	-0.54	-0.61	-1.29
Levered Free Cash Flow	-107.03	-184.2	-123.43	-53.56	-111	-294.46
Unlevered Free Cash Flow	-157.33	-180.91	-168.03	-101.24	-98.63	-67.1

Updated Aug 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q